Polypharmacology translates between species and phylogenetic distance: A functional, bioinformatic, and structural study on organic anion transporting polypeptides.

IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Katja Stefan, Vigneshwaran Namasivayam, Mst Tazmin Akhter, Gergely Gyimesi, Muhammad Rafehi, Hauke Busch, Tomasz Trombik, Till Luckenbach, Jörg König, Sven Marcel Stefan
{"title":"Polypharmacology translates between species and phylogenetic distance: A functional, bioinformatic, and structural study on organic anion transporting polypeptides.","authors":"Katja Stefan, Vigneshwaran Namasivayam, Mst Tazmin Akhter, Gergely Gyimesi, Muhammad Rafehi, Hauke Busch, Tomasz Trombik, Till Luckenbach, Jörg König, Sven Marcel Stefan","doi":"10.1016/j.bcp.2025.117049","DOIUrl":null,"url":null,"abstract":"<p><p>Recently, we postulated the existence of 'multitarget binding sites', reoccurring structural motifs that interconnect otherwise structurally, functionally, and/or phylogenetically distant proteins. In this study, we functionally assessed a selection of 23 multitarget ATP-binding cassette (pan-ABC) transporter modulators against zebrafish (Danio rerio) organic anion transporting polypeptide (drOatp1d1), a transport protein of the solute carrier (SLC) superfamily. Zebrafishes are important in vivo models in drug development to evaluate drug pharmacokinetics and pharmacodynamics. In total, 87.0% of the compounds were identified as drOatp1d1 transport inhibitors despite the relative phylogenetic distance of drOatp1d1 to other Oatps/OATPs. The observed effects resembled the ones observed for human OATP1A2, OATP1B1, OATP1B3, and OATP2B1, and potent hit molecules appeared to bind to a potential drOatp1d1 binding site derived from a OATP1B1 cryo-EM structure - strengthening the notion of common structural motifs between membrane transporters. The bioactivity of Pranlukast (PRA) on human OATPs could be accurately predicted based on its activity on drOatp1d1. The collection of pan-ABC transporter modulators also showed activity against other zebrafish (i.e., drAbcb4) and non-zebrafish (i.e., mumAbca1) membrane transporters, ultimately rendering it a suitable tool to translate between species to tackle the undruggability of membrane transporters and potentially other proteins by addressing conserved structural motifs.</p>","PeriodicalId":8806,"journal":{"name":"Biochemical pharmacology","volume":" ","pages":"117049"},"PeriodicalIF":5.3000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.bcp.2025.117049","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Recently, we postulated the existence of 'multitarget binding sites', reoccurring structural motifs that interconnect otherwise structurally, functionally, and/or phylogenetically distant proteins. In this study, we functionally assessed a selection of 23 multitarget ATP-binding cassette (pan-ABC) transporter modulators against zebrafish (Danio rerio) organic anion transporting polypeptide (drOatp1d1), a transport protein of the solute carrier (SLC) superfamily. Zebrafishes are important in vivo models in drug development to evaluate drug pharmacokinetics and pharmacodynamics. In total, 87.0% of the compounds were identified as drOatp1d1 transport inhibitors despite the relative phylogenetic distance of drOatp1d1 to other Oatps/OATPs. The observed effects resembled the ones observed for human OATP1A2, OATP1B1, OATP1B3, and OATP2B1, and potent hit molecules appeared to bind to a potential drOatp1d1 binding site derived from a OATP1B1 cryo-EM structure - strengthening the notion of common structural motifs between membrane transporters. The bioactivity of Pranlukast (PRA) on human OATPs could be accurately predicted based on its activity on drOatp1d1. The collection of pan-ABC transporter modulators also showed activity against other zebrafish (i.e., drAbcb4) and non-zebrafish (i.e., mumAbca1) membrane transporters, ultimately rendering it a suitable tool to translate between species to tackle the undruggability of membrane transporters and potentially other proteins by addressing conserved structural motifs.

多药理学在物种和系统发育距离之间的转化:有机阴离子转运多肽的功能、生物信息学和结构研究。
最近,我们假设存在“多靶点结合位点”,即重复出现的结构基序,这些结构基序在结构、功能和/或系统发育上遥远的蛋白质之间相互连接。在这项研究中,我们功能性评估了23种多靶点atp结合盒(pan-ABC)转运蛋白调节剂对斑马鱼(Danio rerio)有机阴离子转运多肽(drOatp1d1)的抑制作用,drOatp1d1是一种溶质载体(SLC)超家族的转运蛋白。斑马鱼是药物开发中重要的体内模型,可用于评价药物的药代动力学和药效学。尽管drOatp1d1与其他Oatps/ Oatps存在相对的系统发育距离,但总的来说,87.0%的化合物被鉴定为drOatp1d1转运抑制剂。观察到的效果类似于在人类OATP1A2、OATP1B1、OATP1B3和OATP2B1中观察到的效果,并且有效的命中分子似乎结合了来自OATP1B1低温电镜结构的潜在的drOatp1d1结合位点,从而加强了膜转运蛋白之间共同结构基元的概念。Pranlukast (PRA)对人ooatp的生物活性可以根据其对drOatp1d1的活性准确预测。pan-ABC转运蛋白调节剂的收集也显示出对其他斑马鱼(即drAbcb4)和非斑马鱼(即mumAbca1)膜转运蛋白的活性,最终使其成为物种间翻译的合适工具,通过定位保守的结构基元来解决膜转运蛋白和潜在的其他蛋白质的不可药物性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biochemical pharmacology
Biochemical pharmacology 医学-药学
CiteScore
10.30
自引率
1.70%
发文量
420
审稿时长
17 days
期刊介绍: Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics. The journal''s target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process. All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review. While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信